Description
PDF Product Sheet Duvaxyn IE Plus
Composition
Each dose of 1.5ml contains antigens of equine influenza viruses:
| Virus subtype A/equi/1/Prague/56 (H7N7) | > 1/16 | HAR |
| Virus subtype A/equi/2/Newmarket/1/93 (H3N8) | > 1/16 | HAR |
| Virus subtype A/equi/2/Suffolk/89 (H3N8) | > 1/16 | HAR |
| Clostridium tetani toxoid | > 150 | I.U. |
Characteristics
Influenza- and tetanus-vaccine for horses. May be used during gestation.
Indications
Active immunization of healthy horses from the age of 5 months on against tetanus and clinical symptoms caused by influenza viruses A/equi/1/Prague/56 (H7N7), A/equi/2/Newmarket/1/93 (H3N8) and A/equi/2/Suffolk/89 (H3N8). After injection according to schedule, immunity of 6 months has been made plausible against disorders induced by A/equi/1/Prague/56 (H7N7) and A/equi/2/Suffolk/89 (H3N8). For disorders induced by A/equi/2/Newmarket/1/93 (H3N8) immunity of a few months has been made plausible. Immunity against tetanus has been made plausible from 3 weeks on.